Classical complement activation on human erythrocytes in subjects with systemic lupus erythematosus and a history of autoimmune hemolytic anemia.
Classical complement activation on human erythrocytes in subjects with systemic lupus erythematosus and a history of autoimmune hemolytic anemia.
复制标题
全身性红斑狼疮和自身免疫性溶血性贫血病史的受试者中人类红细胞的经典补体激活。
DOI:
10.1177/0961203320936347
复制
发表时间:
2020-09
期刊:
影响因子:
2.6
通讯作者:
Cunnion K
中科院分区:
文献类型:
--
作者:
Hair P;Goldman DW;Li J;Petri M;Krishna N;Cunnion K
Autoimmune hemolytic anemia (AIHA) is a serious manifestation of systemic lupus erythematosus (SLE) associated with significant morbidity and mortality. In order to more fully understand the causative pathways, we utilized sera from subjects with SLE and active AIHA, or a history of AIHA, to evaluate the classical complement pathway, anti- erythrocyte antibodies, and immune complexes. To evaluate antibody-mediated complement activation on the surface of erythrocytes, as occurs in AIHA, blood type O erythrocytes were incubated with sera from 19 subjects with SLE and a history of AIHA. Circulating anti- erythrocyte antibodies and immune complexes were measured with ELISA-based assays. In total, 90% of subjects with SLE and a history of AIHA, but not active clinical hemolysis, had measurable anti- erythrocyte antibodies. Of those with anti-erythrocyte antibody, 53% demonstrated complement opsonization on the erythrocyte surface >twofold above negative control and 29% generated the anaphylatoxin C5a. For subjects with SLE and a history of AIHA, the persistence of circulating anti-erythrocyte antibodies and resultant erythrocyte complement opsonization and anaphylatoxin generation suggests the possibility that these complement effectors contribute to chronic morbidity and risk of AIHA relapse.
登录
查看更多内容
影响因子:
2.6
作者:
Orbai AM;Truedsson L;Sturfelt G;Nived O;Fang H;Alarcón GS;Gordon C;Merrill J;Fortin PR;Bruce IN;Isenberg DA;Wallace DJ;Ramsey-Goldman R;Bae SC;Hanly JG;Sanchez-Guerrero J;Clarke AE;Aranow CB;Manzi S;Urowitz MB;Gladman DD;Kalunian KC;Costner MI;Werth VP;Zoma A;Bernatsky S;Ruiz-Irastorza G;Khamashta MA;Jacobsen S;Buyon JP;Maddison P;Dooley MA;Van Vollenhoven RF;Ginzler E;Stoll T;Peschken C;Jorizzo JL;Callen JP;Lim SS;Fessler BJ;Inanc M;Kamen DL;Rahman A;Steinsson K;Franks AG Jr;Sigler L;Hameed S;Pham N;Brey R;Weisman MH;McGwin G Jr;Magder LS;Petri M
通讯作者:
Petri M
DOI:
10.1159/000439002
发表时间:
2015-09
期刊:
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie
影响因子:
--
作者:
Barcellini W
通讯作者:
Barcellini W
影响因子:
3.5
作者:
Lafarge, Antoine;Bertinchamp, R.;Mariotte, E.
通讯作者:
Mariotte, E.
影响因子:
4.8
作者:
Harris, FM;Smith, SK;Bell, JD
通讯作者:
Bell, JD
影响因子:
2.4
作者:
Berentsen, Sigbjorn;Randen, Ulla;Tjonnfjord, Geir E.
通讯作者:
Tjonnfjord, Geir E.